Emisphere files second generation IND

Published: 2-Mar-2001


An IND has been filed with the FDA by Emisphere to start human clinical testing of its improved delivery agent for heparin. The agent, coded SNAD, is designed for making orally-available solid dosage formulations of heparin and LMWH.

See more

You may also like

Manufacturing
Change any label roll without interruption

Change any label roll without interruption

Read more
HERMA expands AutoSplicer with optional cutting system

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Japanese researchers report advances in liver disease treatment and cancer screening Two research teams in Japan have published findings that could open new avenues in metabolic disease treatment and non-invasive cancer screening
  3. Bausch and Lomb hit with FDA Warning Letter for persistent microbial contamination The regulator cited persistent out-of-limit microbial recoveries in ISO 5 areas, deficiencies in aseptic processing and airflow controls and an ineffective quality system at Bausch and Lomb's Tampa manufacturing facility
  4. When the recipe becomes a recall: controlling ingredient risk at weigh and dispense Most manufacturing systems are good at repeating instructions. That is precisely why ingredient control matters. If the wrong formula, material, lot or quantity - or an uncorrected potency variation —enters the process, the equipment downstream can efficiently and consistently make the wrong product
  5. Hovione opens New Jersey facility, doubling US spray drying capacity with PSD-3 dryers The 31,000 sq ft East Windsor site completes Hovione's $100m US investment, offering an integrated ASD development-to-commercial pathway under one quality system — and a 125,000 sq ft expansion is already planned for the adjacent plot

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing
Change any label roll without interruption

Change any label roll without interruption

HERMA expands AutoSplicer with optional cutting system
Manufacturing
Piramal Pharma Solutions advances sustainability efforts with solar power plant addition at Morpeth, UK Site

Piramal Pharma Solutions advances sustainability efforts with solar power plant addition at Morpeth, UK Site

Piramal Pharma Solutions is installing a ground-mounted solar power plant (4.3 MWp) at its integrated drug substance and drug product site in Morpeth, UK. The new plant will provide renewable energy directly to the site through a behind-the-meter setup, supporting Piramal’s commitment to reduce Scope 1 and Scope 2 greenhouse gas emissions by 42% by FY2030
Regulatory
Qinecsa selected for Africa-wide medicines safety platform

Qinecsa selected for Africa-wide medicines safety platform

The pharmacovigilance specialist will provide technology and technical delivery for the African Medicines Agency’s new AfriVigilance surveillance system
Regulatory
Pepaxti gains positive CHMP opinion for third-line multiple myeloma treatment

Pepaxti gains positive CHMP opinion for third-line multiple myeloma treatment

Oncopeptides’ melflufen-based therapy could reach an expanded European patient population if the European Commission approves the proposed label extension
Manufacturing
Sachet demand puts formulation science in focus as BENEO heads to CPHI Milan 2026

Sachet demand puts formulation science in focus as BENEO heads to CPHI Milan 2026

Visitors to Booth 1B65 will be able to access technical consultation and samples covering the full range of BENEO's excipient portfolio
Manufacturing
One of the most complex micronisation challenges: Fluticasone propionate

One of the most complex micronisation challenges: Fluticasone propionate

How we addressed the caking phenomenon through our expertise and extensive range of jet mills | D.Sc. Federica Del Matti – FPS Pharma, MEC Manager
Regulatory
Pharma and biotech industry audit services for GMP, GxP and supplier compliance

Pharma and biotech industry audit services for GMP, GxP and supplier compliance

NSF experts perform audits and mock inspections across the product lifecycle. Read the article to find out more its audit services
Subscribe now